Related Experiment Video

Updated: Aug 9, 2026

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
05:19

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Future innovations in treating advanced prostate cancer

Pratik Desai1, Juan A Jiménez, Chinghai Kao

  • 1Department of Urology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

The Urologic Clinics of North America
|April 25, 2006
PubMed

Insights

Novel prostate cancer therapies are under investigation due to inadequate treatments for advanced stages. Experimental approaches like gene therapy may replace hormone ablation, offering better quality of life and disease control.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Prostate cancer is a prevalent disease with inadequate treatments for advanced stages.
  • Current therapies prolong survival but often lead to recurrence or disease progression.
  • Hormone ablation therapy, while common, has significant side effects and offers only temporary disease control.

Purpose of the Study:

  • To review novel therapeutic strategies for prostate cancer.
  • To discuss the potential of gene therapy, antiangiogenic therapy, and immune-based therapy.
  • To explore alternatives to current hormone ablation treatments for advanced prostate cancer.

Main Methods:

  • Review of current literature on prostate cancer treatment modalities.
  • Discussion of emerging experimental therapies including gene, antiangiogenic, and immune-based approaches.
  • Analysis of the molecular underpinnings of cancer to inform therapeutic development.

Main Results:

  • Novel therapeutic approaches are being developed targeting molecular events in cancer.
  • Gene therapy, antiangiogenic therapy, and immune-based therapy show promise.
  • These experimental modalities could potentially overcome limitations of current treatments.

Conclusions:

  • Advanced prostate cancer requires innovative treatment strategies.
  • Gene therapy, antiangiogenic therapy, and immune-based therapy represent promising avenues.
  • These novel approaches may offer improved efficacy and quality of life compared to hormone ablation.

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...